Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Homing in on mechanisms linking breast density to breast cancer risk.

Brower V.

J Natl Cancer Inst. 2010 Jun 16;102(12):843-5. doi: 10.1093/jnci/djq230. Epub 2010 Jun 8. No abstract available.

PMID:
20530764
2.

Insulin-like growth factors and risk of kidney cancer in men.

Major JM, Pollak MN, Snyder K, Virtamo J, Albanes D.

Br J Cancer. 2010 Jun 29;103(1):132-5. doi: 10.1038/sj.bjc.6605722. Epub 2010 Jun 1.

3.

Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004.

Nimptsch K, Platz EA, Pollak MN, Kenfield SA, Stampfer MJ, Willett WC, Giovannucci E.

Int J Cancer. 2011 Feb 1;128(3):660-7. doi: 10.1002/ijc.25381.

4.

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.

Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, Reeves GK, Roddam AW.

Lancet Oncol. 2010 Jun;11(6):530-42. doi: 10.1016/S1470-2045(10)70095-4. Epub 2010 May 14.

5.

Body fatness at young ages and risk of breast cancer throughout life.

Baer HJ, Tworoger SS, Hankinson SE, Willett WC.

Am J Epidemiol. 2010 Jun 1;171(11):1183-94. doi: 10.1093/aje/kwq045. Epub 2010 May 11.

6.

Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors.

Walker K, Fletcher O, Johnson N, Coupland B, McCormack VA, Folkerd E, Gibson L, Hillier SG, Holly JM, Moss S, Dowsett M, Peto J, dos Santos Silva I.

Cancer Res. 2009 Aug 15;69(16):6490-9. doi: 10.1158/0008-5472.CAN-09-0280.

7.

Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort.

Park SL, Goodman MT, Zhang ZF, Kolonel LN, Henderson BE, Setiawan VW.

Int J Cancer. 2010 Jan 15;126(2):490-9. doi: 10.1002/ijc.24718.

8.

Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.

Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Pollak MN, Rosner B, Tamimi RM.

Int J Cancer. 2010 Jan 1;126(1):180-90. doi: 10.1002/ijc.24674.

9.

Body size in early life and risk of epithelial ovarian cancer: results from the Nurses' Health Studies.

Baer HJ, Hankinson SE, Tworoger SS.

Br J Cancer. 2008 Dec 2;99(11):1916-22. doi: 10.1038/sj.bjc.6604742. Epub 2008 Oct 28.

10.

Insulin and insulin-like growth factor signalling in neoplasia.

Pollak M.

Nat Rev Cancer. 2008 Dec;8(12):915-28. doi: 10.1038/nrc2536. Review. Erratum in: Nat Rev Cancer. 2009 Mar;9(3):224.

PMID:
19029956
11.

Energy balance, early life body size, and plasma prolactin levels in postmenopausal women.

Su X, Hankinson SE, Clevenger CV, Eliassen AH, Tworoger SS.

Cancer Causes Control. 2009 Mar;20(2):253-62. doi: 10.1007/s10552-008-9240-8. Epub 2008 Oct 14.

12.

Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence.

Ruder EH, Dorgan JF, Kranz S, Kris-Etherton PM, Hartman TJ.

Clin Breast Cancer. 2008 Aug;8(4):334-42. doi: 10.3816/CBC.2008.n.038. Review.

13.

Plasma insulinlike growth factor 1 and binding-protein 3 and risk of myocardial infarction in women: a prospective study.

Page JH, Ma J, Pollak M, Manson JE, Hankinson SE.

Clin Chem. 2008 Oct;54(10):1682-8. doi: 10.1373/clinchem.2008.105825. Epub 2008 Aug 14.

14.

Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies.

Schouten LJ, Rivera C, Hunter DJ, Spiegelman D, Adami HO, Arslan A, Beeson WL, van den Brandt PA, Buring JE, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Lacey JV Jr, Leitzmann M, Lukanova A, Marshall JR, Miller AB, Patel AV, Rodriguez C, Rohan TE, Ross JA, Wolk A, Zhang SM, Smith-Warner SA.

Cancer Epidemiol Biomarkers Prev. 2008 Apr;17(4):902-12. doi: 10.1158/1055-9965.EPI-07-2524. Epub 2008 Apr 1. Review.

15.

Longitudinal study on birthweight and the incidence of endometrial cancer.

Xue F, Hilakivi-Clarke L, Maxwell G, Hankinson S, Michels K.

Br J Cancer. 2008 Apr 8;98(7):1288-91. doi: 10.1038/sj.bjc.6604304. Epub 2008 Mar 18.

16.

Determination of blood pressure percentiles in normal-weight children: some methodological issues.

Rosner B, Cook N, Portman R, Daniels S, Falkner B.

Am J Epidemiol. 2008 Mar 15;167(6):653-66. doi: 10.1093/aje/kwm348. Epub 2008 Jan 29.

PMID:
18230679
17.

Relationship between antidepressants and IGF-1 system in the brain: possible role in cognition.

Grunbaum-Novak N, Taler M, Gil-Ad I, Weizman A, Cohen H, Weizman R.

Eur Neuropsychopharmacol. 2008 Jun;18(6):431-8. Epub 2007 Oct 24.

PMID:
17961991
18.

Body shape throughout life and correlations with IGFs and GH.

Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE.

Endocr Relat Cancer. 2007 Sep;14(3):721-32. Erratum in: Endocr Relat Cancer. 2008 Mar;15(1):365.

19.

Excess body weight and colorectal cancer risk in Canada: associations in subgroups of clinically defined familial risk of cancer.

Campbell PT, Cotterchio M, Dicks E, Parfrey P, Gallinger S, McLaughlin JR.

Cancer Epidemiol Biomarkers Prev. 2007 Sep;16(9):1735-44.

20.

Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.

Wolpin BM, Michaud DS, Giovannucci EL, Schernhammer ES, Stampfer MJ, Manson JE, Cochrane BB, Rohan TE, Ma J, Pollak MN, Fuchs CS.

Cancer Res. 2007 Aug 15;67(16):7923-8.

Supplemental Content

Support Center